Company page

Pepgen Inc.

Pepgen Inc. (Ticker: PEPG) is a publicly traded company based in the United States, with a market capitalization of approximately $133.5 million. The company is focused on developing innovative therapies for genetic diseases. Pepgen aims to address unmet medical needs through its advanced research and development efforts.